Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-20

Clinical Trial Update: Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy of Cognitive Behavioral Therapy for Insomnia to treat insomnia symptoms in individuals with Multiple Scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cognitive Behavioral Therapy for Insomnia

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Multiple Sclerosis, Insomnia | Phase 2 | Status: RECRUITING